Cargando…
A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo
Developing effective therapies against multiple myeloma (MM) is an unresolved challenge. Phosphatidylinositol-3-kinase (PI3K) activation may be associated with tumor progression and drug resistance, and inhibiting PI3K can induce apoptosis in MM cells. Thus, targeting of PI3K is predicted to increas...
Autores principales: | Glauer, J, Pletz, N, Schön, M, Schneider, P, Liu, N, Ziegelbauer, K, Emmert, S, Wulf, G G, Schön, M P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789203/ https://www.ncbi.nlm.nih.gov/pubmed/24013662 http://dx.doi.org/10.1038/bcj.2013.37 |
Ejemplares similares
-
Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
por: Saha, M N, et al.
Publicado: (2014) -
The Identification
of Potent, Selective, and Brain
Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules
por: Rooney, Timothy P. C., et al.
Publicado: (2022) -
Inhibitors of selectin functions in the treatment of inflammatory skin disorders
por: Schön, Michael P
Publicado: (2005) -
Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia
por: Wong, Jacky, et al.
Publicado: (2014) -
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL
por: Adam, Etai, et al.
Publicado: (2017)